Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Jens De Vos actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Onderzoeksoutput
-
Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients
D'Huyvetter, M., De Vos, J., Caveliers, V., Vaneycken, I., Heemskerk, J., Duhoux, F. P., Fontaine, C., Vanhoeij, M., Windhorst, A. D., van der Aa, F., Hendrikse, N. H., Eersels, J. L. E., Everaert, H., Gykiere, P., Devoogdt, N., Raes, G., Lahoutte, T. & Keyaerts, M., 1 aug 2021, In: Journal of Nuclear Medicine. 62, 8, blz. 1097-1105 9 blz.Onderzoeksoutput: Article › peer review
-
Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
De Baetselier, P., Raes, G., Schoonooghe, S., De Vos, J., Lahoutte, T., Devoogdt, N., Hernot, S., Bala, G. & Tierens, S., 30 jan 2019, IPC-nummer A61K39/00, C07K16/28, EPO, Octrooi Nr. EP2968487B, 17 mrt 2014, Prioriteitsdatum 15 mrt 2013, Prioriteitsnummer US61/798071Onderzoeksoutput: Patent
-
Phase I results of CAM-H2: Safety profile and tumor targeting in patients.
Keyaerts, M., De Vos, J., Duhoux, F. P., Caveliers, V., Fontaine, C. & Vanhoeij, M., 20 mei 2018, In: Journal of Clinical Oncology. 36, 15, blz. e13017-e13017 1 blz.Onderzoeksoutput: Meeting abstract (Journal)
-
Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer
De Vos, J., Devoogdt, N., D'Huyvetter, M. & Lahoutte, T., 2018, Octrooi Nr. US9855348Onderzoeksoutput: Patent
-
Radiolabelled antibody fragments for use in treating cancer
Devoogdt, N., De Vos, J., D'Huyvetter, M. & Lahoutte, T., 30 mei 2018, Octrooi Nr. EP3325020Onderzoeksoutput: Patent
Prijzen
-
Non-invasive imaging of atherosclerosis with Nanobodies
De Vos, Jens (Recipient) & Devoogdt, Nick (Recipient), 25 nov 2010
Prijs: Other distinction
Activiteiten
- 3 Talk or presentation at a conference
-
An 131I-labeled camelid single-domain antibody fragment to treat HER2-overexpressing cancer
Matthias D'Huyvetter (Contributor), Jens De Vos (Contributor), Catarina Xavier (Contributor), Marek Pruszynski (Contributor), Yann Sterckx (Contributor), Sam Massa (Contributor), Geert Raes (Contributor), Vicky Caveliers (Contributor), Michaël Zalutsky (Contributor), Tony Lahoutte (Contributor) & Nick Devoogdt (Speaker)
21 mrt 2018Activiteit: Talk or presentation at a conference
-
A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic islets
Alexander Balhuizen (Contributor), Iris Mathijs (Contributor), Sam Massa (Contributor), Jean-Valery Turatsinze (Contributor), Jens De Vos (Contributor), Stéphane Demine (Contributor), Catarina Xavier (Contributor), Olatz Villate (Contributor), Isabelle Millard (Contributor), Dominique Egrise (Contributor), Carmen Capito (Contributor), Raphael Scharfmann (Contributor), Peter In't Veld (Contributor), Piero Marchetti (Contributor), Serge Muyldermans (Contributor), Serge Goldman (Contributor), Tony Lahoutte (Contributor), Luc Bouwens (Contributor), Decio Eizirik (Contributor) & Nick Devoogdt (Speaker)
13 sep 2017 → 16 sep 2017Activiteit: Talk or presentation at a conference
-
A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic islets
Alexander Balhuizen (Contributor), Iris Mathijs (Contributor), Sam Massa (Contributor), Jean-Valery Turatsinze (Contributor), Jens De Vos (Contributor), Stéphane Demine (Contributor), Catarina Xavier (Contributor), Olatz Villate (Contributor), Isabelle Millard (Contributor), Dominique Egrise (Contributor), Carmen Capito (Contributor), Raphael Scharfmann (Contributor), Peter In't Veld (Contributor), Piero Marchetti (Contributor), Serge Muyldermans (Contributor), Serge Goldman (Contributor), Tony Lahoutte (Contributor), Luc Bouwens (Contributor), Decio Eizirik (Contributor) & Nick Devoogdt (Speaker)
5 apr 2017 → 7 apr 2017Activiteit: Talk or presentation at a conference
Knipsels
-
Camel blood to fight cancer? This VUB spin-off is getting amazing results
Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
17/11/17
1 Mediabijdrage
Pers / media: !!Research
-
Kanker bestrijden met elektrische fietsjes in het bloed
Tony Lahoutte, Ruth Devenyns, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
17/10/17
1 Mediabijdrage
Pers / media: !!Research
-
Lama-antistoffen in strijd tegen kanker
Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
30/03/17
1 Mediabijdrage
Pers / media: !!Research
-
Press release spin-off Camel-IDS and interaction with VUB/UZ Brussel
Nick Devoogdt, Tony Lahoutte, Matthias D'Huyvetter, Jens De Vos, Geert Raes & Claudia Mebis
20/04/16
2 items van Media-aandacht
Pers / media: !!Public Engagement Activities
-
Presentation of Camel-IDS technology and interaction with VUB/UZ Brussel on RTBF news
Nick Devoogdt, Tony Lahoutte, Matthias D'Huyvetter, Jens De Vos, Geert Raes & Claudia Mebis
20/04/16
1 item van Media-aandacht
Pers / media: !!Public Engagement Activities
Scriptie
-
Non-invasive in vivo imaging of atherosclerotic plaques using camelid single-domain antibody-fragments as molecular tracers.
Auteur: De Vos, J. & Ballet, S., sep 2014Begeleider: Ballet, S. (Jury)
Scriptie/Masterproef: Doctoral Thesis
-
Non-invasive in vivo imaging of atherosclerotic plaques using camelid single-domain antibody-fragments as molecular tracers.
Auteur: De Vos, J., Devoogdt, N., Muyldermans, S. & Lahoutte, T., 29 sep 2014Begeleider: Devoogdt, N. (Promotor), Muyldermans, S. (Promotor) & Lahoutte, T. (Co-promotor)
Scriptie/Masterproef: Doctoral Thesis